Wright Medical Grew 11.8% in 2Q19 Amid Cartiva Woes


Wright Medical grew in the low double digits in 2Q19 despite facing a mutiny from legacy Cartiva distributors and challenges from core foot competitors.

Revenue guidance was lowered to the range of $925MM to $930MM, with the projection of Cartiva revenue coming down to $30MM from the initial $47MM given in 4Q18
Cartiva sales...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us